$XNCR
Xencor Inc Stock $xncr

$xncr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023016494 Filed on May 08, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$45.52M	$19.00M
YoY Change	50.74%	-77.78%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.46M	$13.95M
YoY Change	3.33%	23.73%
% of Gross Profit
Research & Development	$60.06M	$64.38M
YoY Change	27.56%	34.81%
% of Gross Profit
Depreciation & Amortization	$2.885M	$2.245M
YoY Change	29.72%	3.08%
% of Gross Profit
Operating Expenses	$71.52M	$78.33M
YoY Change	22.94%	32.69%
Operating Profit	-$26.00M	-$59.37M
YoY Change	-7.15%	-324.31%
Interest Expense	$4.052M	-$6.000K
YoY Change	-169.53%	-99.78%
% of Operating Profit
Other Income/Expense, Net	-$9.000K	-$1.398M
YoY Change	-99.85%	-51.32%
Pretax Income	-$21.95M	-$60.76M
YoY Change	-35.38%	-357.54%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$21.95M	-$60.76M
YoY Change	-35.38%	-357.54%
Net Earnings / Revenue	-48.23%	-319.81%
Basic Earnings Per Share	-$0.37	-$1.02
Diluted Earnings Per Share	-$0.37	-$1.02
COMMON SHARES
Basic Shares Outstanding	60.39M shares	60.03M shares
Diluted Shares Outstanding	59.81M shares	59.77M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$551.4M	$588.0M
YoY Change	7.71%	50.87%
Cash & Equivalents	$34.71M	$72.39M
Short-Term Investments	$516.7M	$515.6M
Other Short-Term Assets	$22.17M	$22.09M
YoY Change	12.35%	-3.99%
Inventory
Prepaid Expenses
Receivables	$20.02M	$19.86M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$593.6M	$630.0M
YoY Change	1.3%	24.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$101.0M	$66.69M
YoY Change	160.05%	134.72%
Goodwill
YoY Change
Intangibles	$18.71M	$18.24M
YoY Change	4.26%	9.17%
Long-Term Investments	$64.21M	$54.21M
YoY Change	-62.57%	-79.94%
Other Assets	$598.0K	$599.0K
YoY Change	-2.45%	-2.28%
Total Long-Term Assets	$184.6M	$173.4M
YoY Change	-30.46%	-50.72%
TOTAL ASSETS
Total Short-Term Assets	$593.6M	$630.0M
Total Long-Term Assets	$184.6M	$173.4M
Total Assets	$778.1M	$803.4M
YoY Change	-8.6%	-6.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.10M	$15.34M
YoY Change	-10.48%	28.86%
Accrued Expenses	$22.67M	$15.14M
YoY Change	38.66%	20.04%
Deferred Revenue	$7.900M	$30.10M
YoY Change	-77.62%	-15.17%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$44.63M	$65.06M
YoY Change	-40.53%	6.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$54.62M	$54.77M
YoY Change	60.9%	61.29%
Total Long-Term Liabilities	$54.62M	$54.77M
YoY Change	60.9%	61.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.63M	$65.06M
Total Long-Term Liabilities	$54.62M	$54.77M
Total Liabilities	$99.25M	$119.8M
YoY Change	-8.94%	26.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$421.0M	-$399.0M
YoY Change	43.45%	53.77%
Common Stock	$607.0K	$605.0K
YoY Change	1.51%	1.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$678.9M	$683.6M
YoY Change
Total Liabilities & Shareholders Equity	$778.1M	$803.4M
YoY Change	-8.6%	-6.35%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$21.95M	-$60.76M
YoY Change	-35.38%	-357.54%
Depreciation, Depletion And Amortization	$2.885M	$2.245M
YoY Change	29.72%	3.08%
Cash From Operating Activities	-$38.20M	-$30.61M
YoY Change	-186.29%	-626.47%
INVESTING ACTIVITIES
Capital Expenditures	$4.936M	$10.78M
YoY Change	-133.7%	416.18%
Acquisitions
YoY Change
Other Investing Activities	$3.531M	$59.33M
YoY Change	-105.79%	-186.29%
Cash From Investing Activities	-$1.405M	$48.14M
YoY Change	-98.14%	-167.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.921M	$922.0K
YoY Change	-23.56%	26.13%
NET CHANGE
Cash From Operating Activities	-38.20M	-$30.61M
Cash From Investing Activities	-1.405M	$48.14M
Cash From Financing Activities	1.921M	$922.0K
Net Change In Cash	-37.68M	$18.45M
YoY Change	30.59%	-128.29%
FREE CASH FLOW
Cash From Operating Activities	-$38.20M	-$30.61M
Capital Expenditures	$4.936M	$10.78M
Free Cash Flow	-$43.14M	-$41.40M
YoY Change	-173.22%	-1211.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001326732
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36182
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Xencor, Inc
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1622502
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	465 North Halstead Street, Suite 200
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Pasadena
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91107
CY2023Q1	dei	City Area Code CityAreaCode	626
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	305-5900
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	XNCR
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	60390793	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72394000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53942000	usd
CY2023Q1	us-gaap	Debt Securities Current DebtSecuritiesCurrent	475922000	usd
CY2022Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	526689000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	39706000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	42431000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19861000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28997000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22093000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23283000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	629976000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	675342000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66685000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59183000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18244000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18500000	usd
CY2023Q1	us-gaap	Debt Securities Noncurrent DebtSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Debt Securities Noncurrent DebtSecuritiesNoncurrent	3826000	usd
CY2023Q1	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	54210000	usd
CY2022Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	54383000	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33697000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34419000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	599000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	613000	usd
CY2023Q1	us-gaap	Assets Assets	803411000	usd
CY2022Q4	us-gaap	Assets Assets	846266000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	15341000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10088000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15140000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18728000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4471000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4708000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30104000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30320000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	65056000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	63844000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54772000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54926000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	119828000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	118770000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60381600	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60381600	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59997713	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59997713	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	605000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	601000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1085651000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1072132000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3625000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6952000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399048000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338285000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	683583000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	727496000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	803411000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	846266000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18962000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	85495000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64379000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47756000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13948000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11273000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	78327000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	59029000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-59365000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	26466000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2892000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	653000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1392000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-96000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-2898000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-3429000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1398000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2872000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-60763000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	23594000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3327000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-5611000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57436000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17983000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59771674	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59407829	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59771674	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61078494	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	727496000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	924000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57436000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12599000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	683583000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	733504000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	731000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17983000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10805000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	763023000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-60763000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	23594000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2245000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2178000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1661000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-543000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12599000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10805000	usd
CY2023Q1	us-gaap	Noncash Project Abandonment Costs NoncashProjectAbandonmentCosts	321000	usd
CY2022Q1	us-gaap	Noncash Project Abandonment Costs NoncashProjectAbandonmentCosts	311000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2898000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-3429000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1379000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-117000	usd
CY2023Q1	xncr	Increase Decrease In Accounts And Other Receivables And Contract With Customer Assets IncreaseDecreaseInAccountsAndOtherReceivablesAndContractWithCustomerAssets	-9135000	usd
CY2022Q1	xncr	Increase Decrease In Accounts And Other Receivables And Contract With Customer Assets IncreaseDecreaseInAccountsAndOtherReceivablesAndContractWithCustomerAssets	26820000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-248000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	251000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1204000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-906000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5254000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2096000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3588000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6831000	usd
CY2023Q1	xncr	Increase Decrease In Lease Liabilities And Right Of Use Assets IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets	331000	usd
CY2022Q1	xncr	Increase Decrease In Lease Liabilities And Right Of Use Assets IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets	1736000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-216000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1806000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30614000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5815000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	95228000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	88764000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	407000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	906000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10783000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2089000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	154562000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	20000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	48144000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-71759000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	922000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	731000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	922000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	731000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18452000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-65213000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53942000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143480000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72394000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78267000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	3327000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-5611000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of interim financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, other comprehensive gain (loss) and the related disclosures. On an ongoing basis, management evaluates its estimates, including estimates related to its accrued clinical trial and manufacturing development expenses, stock-based compensation expense, evaluation of intangible assets, investments, leases and other assets for evidence of impairment, fair value measurements, and contingencies. Significant estimates in these interim financial statements include estimates made for royalty revenue, accrued research and development expenses, stock-based compensation expenses, intangible assets, incremental borrowing rate for right-of-use asset and lease liability, estimated standalone selling price of performance obligations, estimated time for completing delivery of performance obligations under certain arrangements, the likelihood of recognizing variable consideration, the carrying value of equity instruments without a readily determinable fair value, and recoverability of deferred tax assets.</span></div>
CY2023Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q1	xncr	Marketable Securities Impairment Losses And Recoveries MarketableSecuritiesImpairmentLossesAndRecoveries	0	usd
CY2022Q1	xncr	Marketable Securities Impairment Losses And Recoveries MarketableSecuritiesImpairmentLossesAndRecoveries	0	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3300000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-5600000	usd
CY2022Q1	xncr	Equity Securities Impairment EquitySecuritiesImpairment	0	usd
CY2023Q1	xncr	Equity Securities Impairment EquitySecuritiesImpairment	0	usd
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1670665	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60763000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	23594000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59771674	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59407829	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59771674	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61078494	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2556779	shares
CY2023Q1	xncr	Cash And Cash Equivalents And Marketable Securities Amortized Cost CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost	536241000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	55000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3669000	usd
CY2023Q1	us-gaap	Investments Investments	532627000	usd
CY2023Q1	us-gaap	Investments Investments	532627000	usd
CY2022Q4	xncr	Cash And Cash Equivalents And Marketable Securities Amortized Cost CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost	578424000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6945000	usd
CY2022Q4	us-gaap	Investments Investments	571482000	usd
CY2022Q4	us-gaap	Investments Investments	571482000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	479536000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	475922000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	0	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	479536000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	475922000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	351264000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3669000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	457591000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6940000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	3826000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	5000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-2900000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-3400000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-2898000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-3429000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2898000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-3429000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12599000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10805000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12599000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10805000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4789000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6072000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7392000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8589000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8829000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9076000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	66436000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	111183000	usd
CY2023Q1	xncr	Lessee Operating Lease Liability Tenant Allowance LesseeOperatingLeaseLiabilityTenantAllowance	5459000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	46481000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	59243000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4471000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54772000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	59243000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2181000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1562000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	234000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	99000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	2415000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	1661000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	724000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	684000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.089
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y3M18D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
	xncr	Number Of Technology License Agreements NumberOfTechnologyLicenseAgreements	2	agreement
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19000000.0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	85500000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19000000.0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	85500000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	30100000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	35500000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd

Files In Submission

Name	View Source	Status
xncr-20230331_pre.xml	Edgar Link	unprocessable
0001628280-23-016494-index-headers.html	Edgar Link	pending
0001628280-23-016494-index.html	Edgar Link	pending
0001628280-23-016494.txt	Edgar Link	pending
0001628280-23-016494-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xncr-20230331.htm	Edgar Link	pending
xncr-20230331.xsd	Edgar Link	pending
xncr-20230331xexx311.htm	Edgar Link	pending
xncr-20230331xexx312.htm	Edgar Link	pending
xncr-20230331xexx321.htm	Edgar Link	pending
xncr-20230331_cal.xml	Edgar Link	unprocessable
xncr-20230331_def.xml	Edgar Link	unprocessable
xncr-20230331_lab.xml	Edgar Link	unprocessable
xncr-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XNCR
Xencor Inc Stock $xncr

2023 Q2 Form 10-Q Financial Statement

#000162828023016494 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XNCR Xencor Inc Stock $xncr

2023 Q2 Form 10-Q Financial Statement

#000162828023016494 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XNCR
Xencor Inc Stock $xncr